The global single-use bioprocessing market size was valued at US$ 19 billion in 2020 and is expected to hit US$ 52.5 billion by 2030, poised to grow at a noteworthy compound annual growth rate (CAGR) of 16.1% from 2021 to 2030.
The single-use bioprocessing market is significantly driven by the growing demand from the biopharmaceutical industry. Majority of the biopharmaceutical companies are increasingly adopting the single-use bioprocessing technology because the single-use bioprocessing systems increases the efficiency in the process and reduces the costs associated with sterilization, cleaning, and maintenance of steel bioreactors. In biopharmaceutical, the single-use bioprocessing system is used in a wide range of applications such as storage, filtration, purification, and mixing. Moreover, the biopharmaceuticals is rapidly growing. The biopharmaceutical alone forms around 20% of the global pharma market. The extensive use of biopharmaceuticals as therapeutic agents like cell therapies, allergenic agents, and vaccines to name a few. It is also used in the treatment of cancer. Hence, the rapid growth of biopharmaceuticals is significantly boosting the demand for the single-use bioprocessing system.
The growing geriatric population across the globe is expected to fuel the market growth in the upcoming years. According to the United Nations, by 2050, it is estimated that around 1.5 billion of the global population will be of 65 years or above. The geriatric population are more prone to chronic diseases and hence the demand and consumption of biopharmaceutical medicines will rise extensively, thereby propelling the growth of the global single-use bioprocessing market.
By product, the media bags and containers segment led the global single-use bioprocessing market with remarkable revenue share in 2020 and is anticipated to retain its dominance throughout the forecast period. The use of media bags and containers offers low investment, lower wastes emission, and lower operational costs in the biopharmaceutical industry. Moreover, the single-use media bags and containers offers temperature resistance along with durability. Therefore, the extensive use of media bags and containers in the biopharmaceuticals have augmented the segment growth in the recent years.
End User Insights
By end user, the biopharmaceutical manufacturers segment led the market with 58.1% revenue share in 2020 and the rapid growth of biopharmaceuticals industry is significantly boosting the growth of this segment. Moreover, more than 80% of the biopharmaceutical plants have adopted the single-use bioprocessing systems as this is cheaper, efficient, and reliable.
The extensive and increasing use of single-use or disposables by the contract manufacturers have augmented the segment growth. Furthermore, the increased demand for the single-use bioprocessing systems in various bioprocessing services is expected to foster the market growth in the foreseeable future.
By application, the filtration segment led the global single-use bioprocessing market with remarkable revenue share in 2020 and is anticipated to retain its dominance throughout the forecast period. This is attributed to the increasing adoption of single-use bioprocessing system in filtration owing to its efficient filtration even at large scale. It is used for bioburden reduction, polishing of biomolecules, and for ultrafiltration.
Based on the region, the North America dominated the market in 2020 with revenue share of 34% and is estimated to be the most opportunistic market. This is attributed to the rapid growth and development of biopharmaceutical industry in the region. Moreover, the outbreak of the COVID-19 pandemic stimulated the government to invest heavily in the research and development of the COVID-19 vaccines, diagnostics tests, and drugs. The US government sanctioned over US$ 480 million to Moderna, Inc., for the development of COVID-19 vaccines. The Canada government spent around US$ 160 million in 2020, towards the development of vaccines and drugs for COVID-19 treatment.
The presence of giant players, largescale production units, growing adoption of disposables, increased expenditure in health care, and highly developed healthcare infrastructure are the top factors augmenting the North America single-use bioprocessing market. Moreover, the numerous contract manufacturers and the growing usage of disposables amongst them is exponentially driving the single-use bioprocessing market in the region.
The Asia Pacific has potential growth opportunities owing to the growing biopharmaceutical market in the nations such as China, Japan, and India. Moreover, rising investments by the biotechnology and pharmaceutical companies and the rapid growth of the contract manufacturers may lead to the emergence of Asia Pacific to be the manufacturing hub for the pharmaceuticals. Hence, the region may contribute significantly towards the growth of the single-use bioprocessing market in the forthcoming years.
Key Companies & Market Share Insights
The market is moderately fragmented with the presence of several local companies. These market players are striving to gain higher market share by adopting strategies, such as investments, partnerships, and acquisitions & mergers. Companies are also spending on the development of improvedand efficient solutions. Moreover, they are also focusing on maintaining competitive pricing.
In February 2020, MabPlex, a contract manufacturing company, launched two new cell culture production lines with 2000-liter disposable bioreactors. The various developmental strategies undertaken by key market players increases competition and contributes significantly towards the development of single-use bioprocessing market.
Some of the prominent players in the single-use bioprocessing market include:
Report Scope of the Single Use Bioprocessing Market
|Market Size||USD 52.5 Billion by 2030|
|Growth Rate||CAGR of 16.1% From 2021 to 2030|
|Largest Market||North America|
|Fastest Growing Market||Asia Pacific|
|Forecast Period||2021 to 2030|
|Segments Covered||Product, End User, Application, Workflow, Region|
|Companies Mentioned||PBS Biotech, Inc., Thermo Fisher Scientific, Inc., Sartorius AG, Merck KGaA, Entegris, Inc., Pall Corporation, Corning Incorporated, Eppendorf AG, Infors AG, General Electric Company (GE Healthcare), Lonza, Rentschler Biopharma SE|
Segments Covered in the Report
By End User
No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence client